Phillip S. Kim
- Role
- CEO at Trutino Biosciences
- Location
- San Diego, CA, US
- LinkedIn followers
- 500 followers
About Phillip S. Kim
Biotech innovator and strategic leader with a proven track record of building and scaling…
Experience
CEO
Jan 2018 — Present
Trutino Biosciences is a research-driven biopharmaceutical company with a mission to restore immuno-balance in cancer patients by developing the next generation cytokine therapies that can safely activate tumor-fighting immune cells at the disease site without causing adverse side effects. Trutino’s proprietary On-Demand-Cytokine (ODC) platform technology enables the design of therapeutic candidates that can be systemically delivered in an inactive cytokine form and be locally activated directly at the tumor site, thereby avoiding the extreme toxicity of conventional cytokine therapies, and potentially improving efficacy either as a single agent or in combination with other treatment modalities.
Skills
- Fda
- Pharmaceutical Industry
- Gmp
- Management
- Lifesciences
- Technology Transfer
- Research and Development (R&D)
- Science
- Life Sciences
- Cell Culture
- Clinical Research
- Biotechnology
- Cell Biology
- Business Development
- R&D
- Start-Ups
- Biopharmaceuticals
- Molecular Biology
- Commercialization
- Cancer
- Clinical Trials
- Genomics
- Assay Development
- Microbiology
- Immunology
- Validation
- Drug Discovery
- Strategic Planning
- Biochemistry
- Clinical Development
- Drug Development
- Oncology
- Cell
- Infectious Diseases
- Genetics
- Cross-Functional Team Leadership
- Leadership
- Product Development
- Medical Devices
- Biomarker Discovery
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.